speb/financial-data huggingface dataset:
CLNN income_statement (annual, 2025-12-31) — +Operating Expense: 21973000.00
CLNN income_statement (quarterly, 2025-12-31) — +Operating Expense: 7298000.00
CLNN income_statement (annual, 2025-12-31) — +Total Revenue: 200000.00
CLNN income_statement (quarterly, 2025-12-31) — +Total Revenue: 77000.00
CLNN balance_sheet (annual, 2025-12-31) — Accounts Payable: 892000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 892000.00
CLNN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 0.00
CLNN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 0.00
CLNN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -9361000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -9361000.00
CLNN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 290531000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 290531000.00
CLNN income_statement (annual, 2025-12-31) — Basic Average Shares: 9858907.00
CLNN income_statement (annual, 2025-12-31) — Basic EPS: -2.65
CLNN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 12213000.00
CLNN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7983000.00
CLNN cash_flow (annual, 2025-12-31) — Capital Expenditure: -39000.00
CLNN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -28000.00
CLNN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4058000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4058000.00
CLNN balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
CLNN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5189000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5189000.00
CLNN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5189000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5189000.00
CLNN balance_sheet (annual, 2025-12-31) — Cash Equivalents: 2211000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 2211000.00
CLNN balance_sheet (annual, 2025-12-31) — Cash Financial: 2978000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 2978000.00
CLNN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11518000.00
CLNN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2070000.00
CLNN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -39000.00
CLNN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -28000.00
CLNN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -18546000.00
CLNN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4799000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Account Payable: -348000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -477000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -2219000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 553000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Inventory: 31000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Inventory: 24000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1000000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -209000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Payable: -348000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Payable: -477000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2567000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 76000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 119000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 936000.00
CLNN cash_flow (annual, 2025-12-31) — Change In Receivables: 64000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 0.00
CLNN cash_flow (annual, 2025-12-31) — Change In Working Capital: -3353000.00
CLNN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 827000.00
CLNN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 64000.00
CLNN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 0.00
CLNN cash_flow (annual, 2025-12-31) — Changes In Cash: -7067000.00
CLNN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2757000.00
CLNN balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
CLNN balance_sheet (annual, 2025-12-31) — Common Stock Equity: -17592000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -17592000.00
CLNN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 10402000.00
CLNN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2159000.00
CLNN balance_sheet (annual, 2025-12-31) — Construction In Progress: 1298000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1298000.00
CLNN income_statement (annual, 2025-12-31) — Cost Of Revenue: 43000.00
CLNN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 23000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 359000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 359000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Assets: 8977000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Assets: 8977000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 808000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 808000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Debt: 4074000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Debt: 4074000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4882000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4882000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1507000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1507000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1507000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1507000.00
CLNN balance_sheet (annual, 2025-12-31) — Current Liabilities: 10776000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10776000.00
CLNN cash_flow (annual, 2025-12-31) — Depreciation: 1495000.00
CLNN cash_flow (quarterly, 2025-12-31) — Depreciation: 360000.00
CLNN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1495000.00
CLNN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 360000.00
CLNN income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 144000.00
CLNN income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 21000.00
CLNN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1495000.00
CLNN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 360000.00
CLNN income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 144000.00
CLNN income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 21000.00
CLNN income_statement (annual, 2025-12-31) — Depreciation Income Statement: 144000.00
CLNN income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 21000.00
CLNN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 8156000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 8156000.00
CLNN income_statement (annual, 2025-12-31) — Diluted Average Shares: 9858907.00
CLNN income_statement (annual, 2025-12-31) — Diluted EPS: -2.65
CLNN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -9226000.00
CLNN income_statement (annual, 2025-12-31) — EBIT: -23491000.00
CLNN income_statement (quarterly, 2025-12-31) — EBIT: -8480000.00
CLNN income_statement (annual, 2025-12-31) — EBITDA: -21996000.00
CLNN income_statement (quarterly, 2025-12-31) — EBITDA: -8120000.00
CLNN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 101000.00
CLNN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 21000.00
CLNN cash_flow (annual, 2025-12-31) — End Cash Position: 5247000.00
CLNN cash_flow (quarterly, 2025-12-31) — End Cash Position: 5247000.00
CLNN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 11518000.00
CLNN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2070000.00
CLNN balance_sheet (annual, 2025-12-31) — Finished Goods: 14000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 14000.00
CLNN cash_flow (annual, 2025-12-31) — Free Cash Flow: -18585000.00
CLNN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4827000.00
CLNN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 885000.00
CLNN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 1063000.00
CLNN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CLNN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -885000.00
CLNN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1063000.00
CLNN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 172000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 172000.00
CLNN income_statement (annual, 2025-12-31) — General And Administrative Expense: 8430000.00
CLNN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1812000.00
CLNN balance_sheet (annual, 2025-12-31) — Gross PPE: 18457000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 18457000.00
CLNN income_statement (annual, 2025-12-31) — Gross Profit: 157000.00
CLNN income_statement (quarterly, 2025-12-31) — Gross Profit: 54000.00
CLNN income_statement (annual, 2025-12-31) — Insurance And Claims: 725000.00
CLNN income_statement (quarterly, 2025-12-31) — Insurance And Claims: 181000.00
CLNN income_statement (annual, 2025-12-31) — Interest Expense: 2682000.00
CLNN income_statement (quarterly, 2025-12-31) — Interest Expense: 746000.00
CLNN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2682000.00
CLNN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 746000.00
CLNN income_statement (annual, 2025-12-31) — Interest Income: 223000.00
CLNN income_statement (quarterly, 2025-12-31) — Interest Income: 40000.00
CLNN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 223000.00
CLNN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 40000.00
CLNN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1043000.00
CLNN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 87000.00
CLNN balance_sheet (annual, 2025-12-31) — Inventory: 37000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Inventory: 37000.00
CLNN balance_sheet (annual, 2025-12-31) — Invested Capital: 23000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 23000.00
CLNN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -39000.00
CLNN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -28000.00
CLNN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 10402000.00
CLNN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2159000.00
CLNN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1500000.00
CLNN balance_sheet (annual, 2025-12-31) — Leases: 9983000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Leases: 9983000.00
CLNN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3250000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3250000.00
CLNN balance_sheet (annual, 2025-12-31) — Long Term Debt: 13541000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13541000.00
CLNN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 16791000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 16791000.00
CLNN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1500000.00
CLNN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -384000.00
CLNN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -89000.00
CLNN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 637000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 637000.00
CLNN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 10402000.00
CLNN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 2159000.00
CLNN balance_sheet (annual, 2025-12-31) — Net Debt: 12426000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Net Debt: 12426000.00
CLNN income_statement (annual, 2025-12-31) — Net Income: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9226000.00
CLNN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -26173000.00
CLNN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -9226000.00
CLNN income_statement (annual, 2025-12-31) — Net Interest Income: -3472000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Interest Income: -919000.00
CLNN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CLNN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CLNN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1116000.00
CLNN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1411000.00
CLNN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1116000.00
CLNN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 1411000.00
CLNN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -3472000.00
CLNN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -919000.00
CLNN balance_sheet (annual, 2025-12-31) — Net PPE: 9096000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Net PPE: 9096000.00
CLNN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -39000.00
CLNN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -28000.00
CLNN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -17592000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -17592000.00
CLNN income_statement (annual, 2025-12-31) — Normalized EBITDA: -21111000.00
CLNN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -7057000.00
CLNN income_statement (annual, 2025-12-31) — Normalized Income: -25288000.00
CLNN income_statement (quarterly, 2025-12-31) — Normalized Income: -8163000.00
CLNN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -18546000.00
CLNN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4799000.00
CLNN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 885000.00
CLNN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1063000.00
CLNN income_statement (annual, 2025-12-31) — Operating Income: -21816000.00
CLNN income_statement (quarterly, 2025-12-31) — Operating Income: -7244000.00
CLNN income_statement (annual, 2025-12-31) — Operating Revenue: 200000.00
CLNN income_statement (quarterly, 2025-12-31) — Operating Revenue: 77000.00
CLNN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10849974.00
CLNN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 10849974.00
CLNN balance_sheet (annual, 2025-12-31) — Other Current Assets: 139000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 139000.00
CLNN balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4074000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4074000.00
CLNN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 172000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 172000.00
CLNN income_statement (annual, 2025-12-31) — Other Gand A: 1436000.00
CLNN income_statement (quarterly, 2025-12-31) — Other Gand A: 268000.00
CLNN income_statement (annual, 2025-12-31) — Other Income Expense: -885000.00
CLNN income_statement (quarterly, 2025-12-31) — Other Income Expense: -1063000.00
CLNN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2218000.00
CLNN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 812000.00
CLNN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 58000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 58000.00
CLNN income_statement (annual, 2025-12-31) — Other Operating Expenses: -612000.00
CLNN income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -38000.00
CLNN balance_sheet (annual, 2025-12-31) — Other Properties: 6539000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Other Properties: 6539000.00
CLNN balance_sheet (annual, 2025-12-31) — Payables: 892000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Payables: 892000.00
CLNN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1251000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1251000.00
CLNN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3136000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3136000.00
CLNN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3022000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3022000.00
CLNN income_statement (annual, 2025-12-31) — Pretax Income: -26173000.00
CLNN income_statement (quarterly, 2025-12-31) — Pretax Income: -9226000.00
CLNN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CLNN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CLNN balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLNN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLNN cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CLNN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CLNN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -39000.00
CLNN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -28000.00
CLNN balance_sheet (annual, 2025-12-31) — Raw Materials: 23000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 23000.00
CLNN balance_sheet (annual, 2025-12-31) — Receivables: 590000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Receivables: 590000.00
CLNN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 43000.00
CLNN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 23000.00
CLNN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1495000.00
CLNN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 360000.00
CLNN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -384000.00
CLNN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -89000.00
CLNN income_statement (annual, 2025-12-31) — Research And Development: 14011000.00
CLNN income_statement (quarterly, 2025-12-31) — Research And Development: 5503000.00
CLNN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CLNN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CLNN balance_sheet (annual, 2025-12-31) — Retained Earnings: -308296000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -308296000.00
CLNN income_statement (annual, 2025-12-31) — Salaries And Wages: 6269000.00
CLNN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1363000.00
CLNN cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
CLNN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CLNN income_statement (annual, 2025-12-31) — Selling General And Administration: 8430000.00
CLNN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1812000.00
CLNN balance_sheet (annual, 2025-12-31) — Share Issued: 10849974.00
CLNN balance_sheet (quarterly, 2025-12-31) — Share Issued: 10849974.00
CLNN income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CLNN income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CLNN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 6382000.00
CLNN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1365000.00
CLNN balance_sheet (annual, 2025-12-31) — Stockholders Equity: -17592000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -17592000.00
CLNN balance_sheet (annual, 2025-12-31) — Tangible Book Value: -17592000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -17592000.00
CLNN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLNN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLNN income_statement (annual, 2025-12-31) — Tax Provision: 0.00
CLNN income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
CLNN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CLNN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CLNN balance_sheet (annual, 2025-12-31) — Taxes Receivable: 590000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 590000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Assets: 18131000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Assets: 18131000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Capitalization: -4051000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -4051000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Debt: 21673000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Debt: 21673000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -17592000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -17592000.00
CLNN income_statement (annual, 2025-12-31) — Total Expenses: 22016000.00
CLNN income_statement (quarterly, 2025-12-31) — Total Expenses: 7321000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 35723000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 35723000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 9154000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 9154000.00
CLNN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24947000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24947000.00
CLNN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -23083000.00
CLNN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -7495000.00
CLNN income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1013000.00
CLNN income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 213000.00
CLNN income_statement (annual, 2025-12-31) — Total Unusual Items: -885000.00
CLNN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1063000.00
CLNN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -885000.00
CLNN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1063000.00
CLNN balance_sheet (annual, 2025-12-31) — Working Capital: -1799000.00
CLNN balance_sheet (quarterly, 2025-12-31) — Working Capital: -1799000.00
CLNN income_statement (quarterly, 2026-03-31) — +Operating Expense: 1707000.00
CLNN income_statement (quarterly, 2026-03-31) — +Total Revenue: 15000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1309000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2998000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -9716000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 297364000.00
CLNN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 11644214.00
CLNN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.69
CLNN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5247000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3843000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5939000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5939000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 3254000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Cash Financial: 2685000.00
CLNN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 5234000.00
CLNN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4528000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 417000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1170000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -17000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -215000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Payable: 417000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -753000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -3279000.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 0.00
CLNN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -4264000.00
CLNN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 0.00
CLNN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 706000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -18806000.00
CLNN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 5324000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1298000.00
CLNN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 0.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 481000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Assets: 13023000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 826000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Debt: 1866000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2692000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 219000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 219000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6730000.00
CLNN cash_flow (quarterly, 2026-03-31) — Depreciation: 355000.00
CLNN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 355000.00
CLNN income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 17000.00
CLNN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 355000.00
CLNN income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 17000.00
CLNN income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 17000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 14385000.00
CLNN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 11644214.00
CLNN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.69
CLNN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — EBIT: -7300000.00
CLNN income_statement (quarterly, 2026-03-31) — EBITDA: -6945000.00
CLNN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 44000.00
CLNN cash_flow (quarterly, 2026-03-31) — End Cash Position: 5997000.00
CLNN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 5234000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 31000.00
CLNN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4528000.00
CLNN cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 347000.00
CLNN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -347000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 216000.00
CLNN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1633000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 18300000.00
CLNN income_statement (quarterly, 2026-03-31) — Gross Profit: 15000.00
CLNN income_statement (quarterly, 2026-03-31) — Insurance And Claims: 151000.00
CLNN income_statement (quarterly, 2026-03-31) — Interest Expense: 791000.00
CLNN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 791000.00
CLNN income_statement (quarterly, 2026-03-31) — Interest Income: 47000.00
CLNN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 47000.00
CLNN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 111000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Inventory: 54000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Invested Capital: -601000.00
CLNN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
CLNN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 5324000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Leases: 9983000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3017000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 16339000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 19356000.00
CLNN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -90000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 637000.00
CLNN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 5324000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Net Debt: 12266000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -8091000.00
CLNN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -8091000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Interest Income: -1077000.00
CLNN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -90000.00
CLNN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -90000.00
CLNN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1077000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Net PPE: 8584000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -18806000.00
CLNN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -6598000.00
CLNN income_statement (quarterly, 2026-03-31) — Normalized Income: -7744000.00
CLNN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4528000.00
CLNN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 347000.00
CLNN income_statement (quarterly, 2026-03-31) — Operating Income: -1692000.00
CLNN income_statement (quarterly, 2026-03-31) — Operating Revenue: 15000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11778307.00
CLNN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 244000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1866000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 216000.00
CLNN income_statement (quarterly, 2026-03-31) — Other Gand A: 246000.00
CLNN income_statement (quarterly, 2026-03-31) — Other Income Expense: -5322000.00
CLNN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5813000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 58000.00
CLNN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -4975000.00
CLNN income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -272000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Other Properties: 6382000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Payables: 1309000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1790000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2029000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3274000.00
CLNN income_statement (quarterly, 2026-03-31) — Pretax Income: -8091000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CLNN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 23000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Receivables: 3512000.00
CLNN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 0.00
CLNN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 355000.00
CLNN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -90000.00
CLNN income_statement (quarterly, 2026-03-31) — Research And Development: 329000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -316387000.00
CLNN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1236000.00
CLNN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1633000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Share Issued: 11778307.00
CLNN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1312000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -18806000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -18806000.00
CLNN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLNN income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
CLNN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CLNN balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 514000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Assets: 21665000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -2467000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Debt: 22048000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -18806000.00
CLNN income_statement (quarterly, 2026-03-31) — Total Expenses: 1707000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 40471000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8642000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 33741000.00
CLNN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2061000.00
CLNN income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 333000.00
CLNN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -347000.00
CLNN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -347000.00
CLNN balance_sheet (quarterly, 2026-03-31) — Working Capital: 6293000.00
CLNX.MC balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
CLNX.MC cash_flow (annual, 2021-12-31) — Common Stock Issuance: 6765675000.00
CLNX.MC cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -317000.00
CLNX.MC balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 0.00
CLNX.MC cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 6765675000.00
CLNX.MC balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 143204000.00
CLNX.MC income_statement (annual, 2021-12-31) — Other Special Charges: -317000.00
CLNX.MC cash_flow (annual, 2021-12-31) — Purchase Of Business: -12358365000.00
CLNX.MC cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
CLNX.MC income_statement (annual, 2021-12-31) — Special Income Charges: 317000.00
CLNX.MC income_statement (annual, 2022-12-31) — +Operating Expense: 3017397000.00
CLNX.MC income_statement (annual, 2022-12-31) — +Total Revenue: 3247713000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Accounts Payable: 560267000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 803185000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2407897000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 15522762000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -24003000.00
CLNX.MC income_statement (annual, 2022-12-31) — Amortization: 1037527000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 51427000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 93242000.00
CLNX.MC income_statement (annual, 2022-12-31) — Basic Average Shares: 672772636.00
CLNX.MC income_statement (annual, 2022-12-31) — Basic EPS: -0.44
CLNX.MC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 3926578000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 31335000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Capital Expenditure: -2568516000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2985855000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Capital Stock: 176619000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1038179000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1038179000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Cash Equivalents: 328326000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Cash Financial: 709853000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Change In Inventory: -1291000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -49681000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Change In Receivables: 34169000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Change In Working Capital: -16803000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Changes In Cash: -2896818000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Common Stock: 176619000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 14222707000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Common Stock Payments: -322917000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Construction In Progress: 1517282000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Assets: 2221626000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 576151000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Debt: 140749000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 716900000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Liabilities: 2264313000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Current Provisions: 30718000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Depreciation: 2320694000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2320694000.00
CLNX.MC income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 2320694000.00
CLNX.MC income_statement (annual, 2022-12-31) — Depreciation Income Statement: 1283167000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 389399000.00
CLNX.MC income_statement (annual, 2022-12-31) — Diluted Average Shares: 672772636.00
CLNX.MC income_statement (annual, 2022-12-31) — Diluted EPS: -0.44
CLNX.MC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -297058000.00
CLNX.MC income_statement (annual, 2022-12-31) — EBIT: 139412000.00
CLNX.MC income_statement (annual, 2022-12-31) — EBITDA: 2460106000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 8419000.00
CLNX.MC cash_flow (annual, 2022-12-31) — End Cash Position: 1038179000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Financial Assets: 161523000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1223716000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Free Cash Flow: -739374000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Goodwill: 6949503000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 26652269000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 827188000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Gross PPE: 16450335000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
CLNX.MC income_statement (annual, 2022-12-31) — Interest Expense: 642294000.00
CLNX.MC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 642294000.00
CLNX.MC income_statement (annual, 2022-12-31) — Interest Income: 21715000.00
CLNX.MC income_statement (annual, 2022-12-31) — Interest Income Non Operating: 21715000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -626125000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Interest Received Cfo: 20702000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Inventory: 4771000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Invested Capital: 32106295000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5949676000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 93242000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 33232000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 3031816000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Land And Improvements: 13626148000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Liabilities Heldfor Sale Non Current: 21814000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2409704000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Long Term Debt: 17742839000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 20152543000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 3031816000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -888137000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 33232000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1031252000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1228097000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Minority Interest: 966693000.00
CLNX.MC income_statement (annual, 2022-12-31) — Minority Interests: 15878000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3390169000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -322917000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Net Debt: 16845409000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income: -297058000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -297058000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -312936000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -297058000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -297058000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -502882000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -312936000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Interest Income: -729095000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -101439000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2143679000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 2143679000.00
CLNX.MC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -729095000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 110448000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Net PPE: 14042438000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2568516000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -12429562000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 120612000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 641090000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4268135000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 51727000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 24326000.00
CLNX.MC income_statement (annual, 2022-12-31) — Normalized EBITDA: 2460851000.00
CLNX.MC income_statement (annual, 2022-12-31) — Normalized Income: -296594397.56
CLNX.MC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1829142000.00
CLNX.MC income_statement (annual, 2022-12-31) — Operating Income: 230316000.00
CLNX.MC income_statement (annual, 2022-12-31) — Operating Revenue: 3247713000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 705356368.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 116537000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 19702766000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 732401000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 623352000.00
CLNX.MC income_statement (annual, 2022-12-31) — Other Operating Expenses: 673787000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Payable: 566077000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Properties: 47473000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Other Receivables: 81030000.00
CLNX.MC income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Payables: 1334704000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 62851000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3663000.00
CLNX.MC income_statement (annual, 2022-12-31) — Pretax Income: -502882000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLNX.MC cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 15269000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Purchase Of Business: -3390169000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Purchase Of Investment: -157827000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2568516000.00
CLNX.MC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2320694000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -888137000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -322917000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Retained Earnings: -297058000.00
CLNX.MC cash_flow (annual, 2022-12-31) — Sale Of Investment: 56388000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Share Issued: 706475375.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 14222707000.00
CLNX.MC balance_sheet (annual, 2022-12-31) — Tangible Book Value: -12429562000.00
CLNX.MC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -281397.56